March 17, 2013
/PRNewswire-USNewswire/ -- Researchers at
Albert Einstein College of Medicine
and the Icahn School of Medicine at
have found that macrophages – white blood cells that play a key role in the immune response – also help to both produce and eliminate the body's red blood cells (RBCs). The findings could lead to novel therapies for diseases or conditions in which the red blood cell production is thrown out of balance. The study, conducted in mice, is published today in the online edition of the journal
"Our findings offer intriguing new insights into how the body maintains a healthy balance of red blood cells," said study leader
Paul Frenette, M.D.
, professor of
and director of the
Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research
at Einstein. "We've shown that macrophages in the bone marrow and the spleen nurture the production of new red blood cells at the same time that they clear aging red blood cells from the circulation. This understanding may ultimately help us to devise new therapies for conditions that lead to abnormal RBC counts, such as hemolytic anemia, polycythemia vera, and acute blood loss, plus aid recovery from chemotherapy and bone marrow transplantation." Einstein has filed a joint patent application with
related to this research, which is currently available for licensing and further commercialization.
Previous studies, all done in the laboratory, had suggested that macrophages in the bone marrow act as nurse cells for erythroblasts, which are RBC precursors. But just how these "erythroblastic islands" (macrophages surrounded by erythroblasts) function in living animals was unclear.